the other side of the debate
You reference Ariosa v Sqnm. Yes, they did lose their appeal. But are you perhaps conflating issues here? As far as I can see, trov is not claiming a METHOD OF USE with their Precision Cancer Monitoring tests in urine. A 'method of use' was claimed by sqnm in order to claim patent right protection to their idea AND science of a pre natal dna detection dx. In other words, sqnm wanted the rights to the IDEA and discovery method of detecting dna from moms blood. Prior to sqnms discovery, no one had even realised this possibility (the dna was in the blood). The court decided they could not grant such a method of use patent as dna is located in the blood wether sqnm discovered that or not. It should be noted that even the judge realises the flaw of the ruling and referenced the supreme court would need to over turn such legal rationale.
Again, trov has patents to protect HOW they sequence via urine but aren't claiming to own the method and/or idea of urine collection for a cancer monitoring test. Sure, other companies can use urine also and likely will. But, they will have to invent their own science to do it (and avoid trovagene patents while they are at it).
did you guys read the comments section in the SA article about the patent issues. they were written from what seemed a very bright and informed BIO investor. Go back and read his comments. I have no idea how to confirm or deny them but they seem to have some merit regarding the timing of the sell off, I dont care to be right just to get it right and this guy brought up some very interesting points. be interested in your feedback ... blessings .
docs will be signed simultaneously with approval
just frustrated... been waiting for this forever. I really thought we would get a ton of upgrades on events and rocket up. Do you think we could base above 40 and make a meaningful move up in the next 30 days ?
1. CANCER DX
A.I'm hearing chatter their new Cancer DX test will be unveiled in Q4.
B: Does it need FDA approval?
C. Has it been approved for reimbursements by health care ?
D. Do they commercial roll-out plan ?
2. BALANCE SHEET
A. BTX is burning 40mm a year and have 31MM in Cash, anyone worried ?
B. An offering could come Sub 2:50 ? or some quasi preferred share deal as they released a few days ago.
Thanks for your time.
Hi Pepsi. I see the ADX is at 25.442 getting higher as 30 usually is showing me a new trend has begun. do you agree with this reading and my analysis. thanks
TTOO is looking very cheap down here for a major disruptive technology that can saves life's and hospitals tons of money..